1 Scope
This document identifies data elements and metadata to represent the information about
tumor mutation burden (TMB) when reporting the value for the biomarker using clinical
massive parallel DNA sequencing.
This document covers the TMB status and related metadata such as mutation type, sequencing
types, and target areas of sequencing from human samples for clinical practice and
research.
This document is not intended
-
— to define experimental protocols or methods for calculating the value of tumor mutation
burden,
-
— for the other biological species, and
-
— for the Sanger sequencing methods.